Beloy, Alvien M.

HRN: 16-92-00  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2023
CO-AMOXICLAV 625MG (TAB)
09/27/2023
10/04/2023
PO
625mg
BID
Multiple STI, Laceration
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: